Nov 21

NSCLC ROS1+ Updates

Live from McKesson Accelerate 2025, Dr. Ira Zackon sits down with Dr. Martin Dietrich to discuss the latest in ROS1+ non-small cell lung cancer. They explore the rarity and significance of ROS1 mutations and clinical presentation. The conversation highlights evolving treatment ... Show More

9m 51s

Nov 21

The Power of Precision Medicine for Patients with NSCLC

Live from McKesson Accelerate 2025, host Suzzette Arnal talks with Dr. Melissa Johnson about how precision medicine is reshaping care for non-small cell lung cancer patients. They cover comprehensive biomarker testing, the role of DNA and RNA-based NGS, and why patient charact ... Show More

12m 48s

Oct 17

IMforte Trial: Redefining First-Line Maintenance Therapy in ES-SCLC

In this episode of OncoTalks, Dr. Paul Conkling and Dr. Eric Nadler take a deep dive into the IMforte trial—a pivotal phase III global study evaluating lurbinectedin and atezolizumab as a first-line maintenance therapy for extensive-stage small-cell lung cancer (ES-SCLC). They ... Show More

10m 40s

Oct 21

Interview: Could we detect breast cancer with a fingerprint? with Dr. Dhivya Srinivasa

Breast cancer is the most common cancer among women globally. And yet, many people pass up opportunities to get screened for the disease, often because of the invasive and sometimes painful process of mammograms. Chemist and professor Simona Francese presents a potentially ground ... Show More

31m 57s

Sep 24

Episode 65. Circulating Tumor DNA in DLBCL with Dr. Ash Alizadeh and Dr. David Russler-Germain

In this episode of Blood Cancer Talks, hosts Eddie, Ashwin, and Raj welcome two distinguished experts to explore the cutting-edge field of circulating tumor DNA (ctDNA) in B-cell lymphomas. Dr. David Russler-Germain, a lymphoma clinician from Siteman Cancer Centre at Washington U ... Show More

53m 8s

Jan 2025

Appropriate Use of Genetic Testing (Republished)

Appropriate Use of Genetic Testing (who, what, when and how?) CME Available: auau.auanet.org/node/41734 ACKNOWLEDGEMENTS: Support provided by independent educational grants from: Lantheus Medical Imaging Novartis Pharmaceuticals Corporation LEARNING OBJECTIVES: At the conclusion ... Show More

38m 7s

Oct 2024

Newly FDA Approved Alzheimer’s Biomarkers Testing: How to Implement Such Tests in Core Laboratory?

The diagnostic paradigm for Alzheimer's disease (AD) has rapidly shifted in the last five years as fluid-based biomarker testing has emerged as a reliable, accurate, and accessible means to detect amyloid pathology when evaluating a patient for cognitive decline. This pod ... Show More

35m 34s

Sep 4

Colorectal Cancer

Ninja Nerds!In this episode of the Ninja Nerd Podcast, Zach and Rob discuss Colorectal Cancer. This comprehensive discussion focuses on the clinical presentation, pathogenesis, and management of one of the most common malignancies encountered in clinical practice ... Show More

37m 25s

Apr 2023

Cancer detection

Diagnosing cancer in primary care is difficult. Many patients present with non-specific symptoms and the positive predictive value of even the ‘red flag’ symptoms is low. In this podcast, Dr Thomas Round and Professor Willie Hamilton discuss the issues around cancer diagnosis in ... Show More

28m 37s

Dec 2024

139. Back to Basics - Early HER2 Breast Cancer

Human epidermal growth factor receptor 2 (HER2) is overexpressed in multiple cancers, including breast, gastric, colorectal, and epithelial ovarian cancers. However, this receptor's complexity doesn't stop there. It has multiple subdomains and various responses to drugs, and t ... Show More

24m 31s

Jun 2025

Reprogramming Immunity: Unlocking CAR-NK Cells with Dr. Hind Rafei

In this episode, Dr. Hind Rafei dives into the cutting-edge world of CAR-NK cell therapy and its potential to revolutionize cancer treatment. Unlike their T-cell counterparts, CAR-NK cells promise enhanced safety and innate tumor-killing ability. But what if their power could ... Show More

26m 51s

Feb 2025

The Role of Ultrasound in HCC Detection: What's New in 2024?

In this episode Dr. Refky Nicola explores the latest updates to LIRADS Ultrasound Surveillance 2024 with guest Dr. Aya Kamaya. Focusing on its role in hepatocellular carcinoma (HCC) screening and how it compares to other imaging modalities. Key topics include the importance of su ... Show More

19m 45s

May 2023

AUANewsWorthy Webinar: An Integrated Biomarker and MRI Risk Assessment Approach to Prostate Cancer Diagnosis

Prostate cancer diagnostic guidelines aim to minimize over-diagnosis of clinically insignificant prostate cancer (Gleason6/GG1). The clinical question before us is how do we enable the best balance, helping to increase compliance with the biopsy recommendation for patients at hig ... Show More

51m 37s

How MRD Testing is Reshaping Breast Canc...